Vasopressin and oxytocin release and the thyroid function

Journal of Physiology and Pharmacology

Volumn 55, Issue 2, 2004, Pages 423-441

  Ciosek, Joanna ^a   Drobnik, J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Hyperthyroidism; Hypothyroidism; Osmotic disturbances; Oxytocin; Vasopressin

Indexed keywords

OXYTOCIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; NEUROHYPOPHYSIS; NONHUMAN; OSMORECEPTION; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; RAT; THYROID FUNCTION; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE; WATER METABOLISM;

ANIMALS; DISEASE MODELS, ANIMAL; DRINKING; HYPERTHYROIDISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; MALE; OXYTOCIN; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; VASOPRESSINS; WATER; WATER DEPRIVATION;

EID: 3142516036     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (76)

1. Shibuki K, Leng G, Way S. Effects of naloxone and of intraperitoneal hypertonic saline upon oxytocin release and upon supraoptic neuronal activity. Neurosci Lett 1988; 88: 75-80.
2. Leng G, Dyball REJ, Luckman SM. Mechanisms of vasopressin secretion. Horm Res 1992; 37: 33-38.
3. Juszczak M, Steger RW, Fadden C, Bartke A. Oxytocin and prolactin release after hypertonic saline administration in melatonin-treated male Syrian hamsters. J Physiol Pharmacol 1996; 47: 289-302.
4. Ciosek J, Stempniak B. Thyrotropin-releasing hormone (TRH) modifies oxytocin release from the hypothalamo-neurohypophysial system in salt-loaded rats. J Physiol Pharmacol 1995; 46: 169-178.
5. Ciosek J. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats. J Physiol Pharmacol 2002; 53: 423-437.
6. Ciosek J, Cisowska A, Da̧browski R. Galanin affects vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in haemorrhaged rats. J Physiol Pharmacol 2003; 54: 233-246.
7. Crowley WR, Armstrong WE. Neurochemical regulation of oxytocin secretion in lactation. Endocr Rev 1992; 13: 33-65.
8. Higuchi T, Tadekoro Y, Honda K, Negoro H. Detailed analysis of blood oxytocin levels during suckling and parturition in the rat. J Endocrinol 1986; 110: 251-256.
9. Luckman SM, Antonijevic I, Leng G et al. The maintenance of normal parturition in the rat requires neurohypophysial oxytocin. JNeuroendocrinol 1993; 5: 7-12.
10. Ježová D, Skultéyová I, Tokarev DI, Bakos P, Vigas M. Vasopressin and oxytocin in stress. Ann NY Acad Sci 1995; 771: 192-203.
11. Bojanowska E, Stempniak B. TGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effect of a TGLP-1 receptor agonist and antagonist. J Physiol Pharmacol 2001; 52: 781-793.
12. Juszczak M. Neurokinin A and the neurohypophysial response to melatonin: in vitro studies. J Physiol Pharmacol 2002; 53: 823-834.
13. Ciosek J, Guzek JW. Thyrotropin-releasing hormone (TRH) and vasopressin and oxytocin release: in vitro as well as in vivo studies. Exp Clin Endocrinol 1992; 100: 152-159.
14. Ciosek J. Influence of thyroliberin (TRH) on hypothalamo-neurohypophysial vasopressin and oxytocin content of rats drinking 2% NaCl. Pol J Pathol 1993; 44: 221-226.
15. Ciosek J, Orłowska-Majdak M. Thyrotropin-releasing hormone (TRH) inhibits the release of vasopressin but not that of oxytocin from the hypothalamo-neurohypophysial system in haemorrhaged rats. Endocr Regul 1995; 29: 47-55.
16. Ciosek J, Guzek JW. Thyrotropin-releasing hormone affects the oxytocin, vasopressin and prolactin release in female rats during midlactation: relation to suckling. J Physiol Pharmacol 1998; 49: 135-150.
17. Ciosek J, Stempniak B. Thyroliberin and the daily rhythm of vasopressin and oxytocin release from the hypothalamo-neurohypophysial system. Pathophysiology 1998; 5: 131-139.
18. Ciosek J, Stempniak B. Thyrotropin-releasing hormone (TRH) inhibits vasopressin and oxytocin release from rat hypothalamo-neurohypophysial explants in vitro. Acta Neurobiol Exp 1996; 56: 35-40.
19. Ciosek J, Stempniak B. Thyrotropin-releasing hormone (TRH) and release of neurohypophysial hormones in the rat. Pol J Endocrinol 1997; 48: 23-34.
20. Adan RA, Cox JJ, van Kats JP, Burbach JP. Thyroid hormone regulates the oxytocin gene. J Biol Chem 1992; 267: 3771-3777.
21. Ceccatelli S, Giardino L, Calzá L. Response of hypothalamic peptide mRNAs to thyroidectomy. Neuroendocrinology 1992; 56: 694-703.
22. Howard RL, Summer S, Rossi N, Kim JK, Schrier RW. Short-term hypothyroidism and vasopressin gene expression in the rat. J Kidn Dis 1992; XIX: 573-577.
23. Thomas A, Kim NB, Amico JA. Thyroidectomy does not alter hypothalamic oxytocin and vasopressin expression in chronically hypernatremic rats. Life Sci 1995; 57: 403-410.
24. Waters AK. Increased vasopressin excretion in patients with hypothyroidism. Acta Endocrinol 1978; 88: 285-290.
25. Macaron C, Famuyiwa O. Hyponatremia of hypothyroidism: appropriate suppresion of antidiuretic hormone levels. Arch Intern Med 1978; 138: 820-822.
26. Kim JK, Summer SN, Schrier RW. Cellular action of arginine vasopressin in the isolated renal tubules of hypothyroid rats. Am J Physiol 1987; 253: F104-F110.
27. Koide Y, Oda K, Shimizu K et al. Hyponatremia without inappropriate secretion of vasopressin in a case of myxedema coma. Endocrinol Jpn 1982; 29: 363-368.
28. Hanna FWF, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopresin. The Lancet 1997; 350: 755-756.
29. Sahun M, Ramon JM, Navarro MA et al. Water metabolism disturbances of different stages of primary thyroid failure. J Endocrinol 2001; 168: 435-445.
30. Sulman FG, Tal E, Pfeifer Y. Intermittent hyperthyreosis - a heat stress syndrome. Horm Metab Res 1975; 7: 424-428.
31. Thoday KL, Mooney CT. Historical, clinical and laboratory features of 126 hyperthyroid cats. Vet Rec 1992; 131: 257-264.
32. Shulte-Wissermann H, Straub E. Effect of L-thyroxine on renal excretion of water and electrolytes in both normal and mercury-intoxicated rats. Urol Res 1980: 8: 189-196.
33. Forsling MD. Measurement of vasopressin in body fluid. In Posterior Pituitary, PH Baylis, PL Padfield (eds). Marcel Dekker Inc, 1985, pp. 161-192.
34. Ciosek J, Guzek JW, Orłowska-Majdak M. Thyrotropin-releasing hormone (TRH) modulates vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in dehydrated rats. J Physiol Pharmacol 1993; 44: 293-302.
35. Leng G, Bicknell RJ. The neurohypophysis. In Neuroendocrinology, SL Lightman, BJ Everitt (eds). Blackwell Scientific Publications, Oxford-London-Edinburgh-Boston-Palo Alto-Melbourne, 1986, pp. 177-196.
36. Wade CE, Bie P, Keil LC, Ramsay DJ. Effects of hypertonic intracarotid infusions on plasma vasopressin concentration. Am J Physiol 1982; 243: E522-E526.
37. Lukic D, Haldar J. Isotonic and hypertonic saline act as stressful stimuli for oxytocinergic system of the pituitary, hypothalamus and spinal cord. Life Sci 1993; 53: 579-584.
38. Neumann I, Ludwig M, Engelmann M, Pittman QJ, Landgraf R. Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrinology 1993; 58: 637-645.
39. Bourque CW, Oliet SHR, Richard D. Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol 1994; 15: 231-274.
40. Ivanyi T, Dohanics J, Verbalis JG. Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion in rats. Neuroendocrinology 1995; 61: 412-420.
41. Ciosek J. Vasopresin and oxytocin release from the neurohypophysis - the current state of knowledge (in Polish). Endokrynol Pol 2000; 51: 113-123.
42. Segerson P, Kauer J, Wolfe KC et al. Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science 1987; 238: 78-80.
43. Koller KJ, Wolf RS, Warden MK, Zoeller RT. Thyroid hormones regulate levels of thyrotropin-releasing hormone mRNA in the paraventricular nucleus. Proc Natl Acad Sci USA 1987; 84: 7329-7333.
44. Taylor T, Wondisford FE, Blaine T, Weintraub BD. The paraventricular nucleus of the hypothalamus has a major role in thyroid hormone feedback regulation of thyrotropin synthesis and secretion. Endocrinology 1990; 126: 317-324.
45. Aizawa T, Greer MA. Delineation of the hypothalamic area controlling thyrotropin secretion in the rat. Endocrinology 1981; 109: 1731-1738.
46. Ishikawa K, Taniguchi Y, Inoue K. Immunocytochemical delineation of thyrotropic area: origin of thyrotropin-releasing hormone in the median eminence. Neuroendocrinology 1988; 47: 384-388.
47. Toni R, Jackson IMD, Lechan RM. Thyrotropin-releasing-hormone- tuberoinfundibular neurons in rat hypothalamus: anatomical basis to suggest ultrashort feedback regulation. Neuroendocrinology 1990; 52: 422-428.
48. Rondeel JM, Klootwijk W, Linkels E, van Haasteren GA, de Greef WJ, Visser TJ. Regulation of thyrotropin-releasing hormone in the posterior pituitary. Neuroendocrinology 1995; 61: 421-429.
49. Pekary AE, Sattin A. Regulation of TRH and TRH-related peptides in rat brain by thyroid and steroid hormones. Peptides 2001; 22: 1161-1173.
50. Bigos R, Ridgeway EC, Kourides A, Maloof F. Spectrum of pituitary alteration with mild and severe thyroid impairment. J Clin Endocrinol Metab 1978; 2: 317-325.
51. Gallagher TF, Helmann L, Finkelstein J et al. Hyperthyroidism and cortisol secretion in man. J Clin Endocrinol Metab 1972; 34: 919-927.
52. Tohei A, Watanabe G, Taya K. Hypersecretion of corticotrophin-releasing hormone and arginine vasopressin in hypothyroid male rats as estimated with push-pull perfusion. J Endocrinol 1998; 156: 395-400.
53. Dakine N, Oliver C, Grino M. Thyroxine modulates corticotropin-releasing factor but not arginine vasopresin gene expression in the hypothalamic paraventricular nucleus of the developing rat. J Neuroendocrinol 2000; 12: 774-783.
54. Jones PM, Burrin JM, Ghatei MA, O'Halloran DJ, Legon S, Bloom SR. The influence of thyroid hormone status on the hypothalamo-hypophyseal growth hormone axis. Endocrinology 1990; 126: 1374-1379.
55. Sowers JSA, Kellett HA, Brown NS, Seth J, Toft AD. Prolactin response to metoclopramide in hyperthyroidism. J Clin Endocrinol Metab 1982; 55: 175-177.
56. Watanabe H, Sasaki S. Effect of thyroid status on the prolactin-releasing action of vasoactive intestinal peptide in humans: comparison with the action of thyrotropin-releasing hormone. Clin Neuroendocrinol 1995; 61: 207-212.
57. Stempniak B, Marczyński A, Da̧browski R. Disorders of thyroid function and hormone release from the rat pituitary. Pol J Endocrinol 2002; 53: 13-22.
58. Hooi SC, Koenig J, Gabriel SM, Maiter D, Martin JB. Influence of thyroid hormone on the concentration of galanin in the rat brain and pituitary. Neuroendocrinology 1990; 51: 351-356.
59. Lam KSL, Lechan RM, Minamitami N, Segerson TP, Reichlin S. Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism. Endocrinology 1989; 124: 1077-1084.
60. Horita A, Carino MA. Centrally administered TRH produces a vasopressor response in rabbit. Proc West Pharmacol Soc 1977; 20: 303-304.
61. Weitzman RE, Firemark NM, Glatz TH, Fisher DA. Thyrotropin releasing hormone stimulates release of arginine vasopressin and oxytocin in vivo. Endocrinology 1979; 104: 904-907.
62. Sowers JR, Hershman JM, Skowsky WR, Carlson HE. Effect of TRH on serum arginine vasopressin in euthyroid and hypothyroid subjects. Horm Res 1976; 7: 232-237.
63. Kasting NW. Simultaneous and independent release of vasopressin and oxytocin in the rat. Can J Physiol Pharmacol 1988; 66: 22-26.
64. Siren AL, Lake CR, Feuersteing G. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat. Circ Res 1988; 62: 139-154.
65. Tohei A, Watanabe, Taya K. Hypersecretion of corticotrophin-releasing hormone and arginine vasopressin in hypothyroid male rats as estimated with push-pull perfusion. J Endocrinol 1998; 156: 395-400.
66. Mogulkoc R, Dogm O, Baltaci K, Yilmaz B, Kelestimur H. Influence of hypovolemic and hypertonic treatments on plasma vasopressin levels and fluid balance in the thyroidectomy-induced hypothyroid rats. Neuroendocrinol Lett 2000; 21: 35-38.
67. Wolf G, Kiessig R, Landgraf R. Levels of vasopressin and oxytocin in neurohypophysis and plasma of the postnatally developing rat and the influence of hypothyroidism on rat fetuses. Exp Clin Endocrinol 1984; 83: 251-255.
68. Rosato RR, Gimenez MS, Jahn GA. Effects of chronic thyroid hormone administration on pregnancy, lactogenesis and lactation in the rat. Acta Endocrinol 1992; 127: 547-554.
69. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion in myxedema. Am J Med 1978; 64: 613-621.
70. Iwasaki Y, Oiso Y, Yamanchi K et al. Osmoregulation of plasma vasopressin in myxedema. J Clin Endocrinol Metab 1990; 70: 534-539.
71. Ali M, Guillon G, Cantan B, Balestre MN, Chicot D, Clos J. A comparative study of plasma vasopressin levels and V1 and V2 vasopressin receptor properties in congenital hypothyroid rat under thyroxine or vasopressin therapy. Horm Metab Res 1987; 19: 624-628.
72. Sahun M, Villabone C, Rosel P et al. Water metabolism disturbances at different stages of primary thyroid failure. J Endocrinol 2001; 168: 435-445.
73. Carter DA, Pardy K, Murphy D. Regulation of vasopressin gene expression: changes in the level, but not the size, of vasopressin mRNA following endocrine manipulations. Cell Mol Neurobiol 1993; 13: 87-95.
74. Marcisz C, Jonderko G, Kucharz EJ. Changes of plasma arginine-vasopressin level in patients with hyperthyroidism during treatment. Med Sci Monit 2001; 7: 409-414.
75. Vargas F, Baz MJ, Luna JD, Andrade J, Jodar E, Haro JM. Urinary excretion of digoxin-like immunoreactive factor and arginine-vasopressin in hyper- and hypo-thyroid rats. Clin Sci 1991; 81: 471-476.
76. Mogulkoc R, Baltaci AK, Yilmaz B, Kelestimur H. Influence of hypovolemic and hypertonic treatments on plasma vasopressin levels and fluid balance in the propylthiouracil-induced hypothyroid rats. Neuroendocrinol Lett 1999; 20: 311-314.